PharmaText vs Veeva Vault PromoMats: What Each Layer Is For

If you are evaluating tooling for pharmaceutical promotional content, you will eventually put these two side by side. That comparison is usually framed badly, including, until recently, by us.

The honest version: Veeva Vault PromoMats is a regulated content management system for the full lifecycle of promotional content. PharmaText is a claim-verification tool that runs at the drafting stage. They sit at different layers. They also overlap more than they used to, and if you are choosing between them, the deciding factor is probably not features at all.

Here is the straight comparison.

What Veeva Vault PromoMats actually does

Veeva positions PromoMats as "a regulated content management application that supports the full lifecycle of promotional content". Per Veeva's own product documentation, that lifecycle spans:

Content creation and Digital Asset Management — the system of record for the asset itself
Review and approval (MLR Review) — routing, reviewer comments, sign-off, versioning, expiry dating
Claims Management — a central claims library where each statement is held with linked references
Content Strategy, Commercial Content Kernel, and modular content functionality
Distribution — integration with CRM, CLM and Approved Email, plus an open API
Brand Portal and automatic eCTD compliance package generation for FDA submissions

This is a large, mature enterprise platform, and it is genuinely the system of record. Nothing here is a substitute for it.

What PharmaText does

PharmaText checks claims against sources at the point of writing. You upload your source PDFs, write or paste your copy, and it verifies each claim against those sources, flags anything unsupported, mis-sourced, or inconsistent with the label, and anchors what passes to the exact supporting line.

That is the entire scope. It does not route content, hold approvals, manage versions, store assets, apply expiry dates, or distribute anything. It produces a verified, anchored draft that goes into whatever system of record you use. See MLR review readiness for what that output looks like in practice.

Side by side

	Veeva Vault PromoMats	PharmaText
Category	Regulated content management (system of record)	Claim verification at drafting
Where it sits	Submission through distribution	Before submission
Review routing & sign-off	Yes	No
Version control, expiry dating	Yes	No
Asset storage / DAM	Yes	No
Claims library	Yes — Claims Management module	No — works against your uploaded PDFs
Claim-to-source anchoring	Yes, within the Vault claims library	Yes, against arbitrary source PDFs
Distribution (CRM, CLM, email)	Yes	No
Buying model	Enterprise licence	$69–199/month, self-serve

Where they genuinely overlap — and it is growing

We should be direct about this, because the older version of our argument was that claim substantiation was a gap upstream of Veeva. That is no longer an accurate description.

Veeva's Claims Management already does claim-to-reference linking with anchors and metadata. Veeva reports "80% claims auto-linked" and "70% claims reuse" through Claims Auto Linking and Claims Harvesting. And Veeva's own page lists a Claims Agent, available August 2026, which it says will "identify and substantiate claims to ensure compliant referencing" with full traceability across marketing materials.

If you hold a PromoMats licence with Claims Management, a meaningful share of what PharmaText does is available to you inside the platform you already own. We would rather tell you that than have you discover it after buying.

So where is the real difference?

Not in the feature list. In who can actually reach the tooling, and when.

Veeva's claims tooling works on claims that live in your Vault claims library. That is exactly right for an in-house brand team at a company with a mature, funded library. It is much less useful in three common situations:

You do not have a Veeva licence. Freelance medical writers, small medcom agencies, and smaller biotechs frequently do not. This is not a feature gap; it is a procurement reality.
You have a licence but not to that Vault. External agencies routinely write content destined for a client's Vault while having no visibility into the client's claims library. They rebuild claims from scratch, and sometimes resubmit wording that was already rejected.
The claim is not in any library yet. New data, a fresh publication, a KOL transcript, a competitor comparison. The claims library helps you reuse what is approved; it does not help you substantiate something new against a PDF you just downloaded.

PharmaText is built for those three cases: verification against whatever sources you actually have, at the moment you are writing, without needing a seat in anyone's Vault.

Which one you need

You need PromoMats (or Aprimo, or Vodori) if you need a system of record: routing, approvals, version control, expiry dating, audit trail, distribution. There is no way around this, and a $69/month tool is not a substitute for it.

You may want PharmaText as well if content reaches your Vault from people who cannot see inside it — agencies, freelancers, contractors — or if a lot of your substantiation work involves fresh sources rather than library reuse.

PharmaText alone may be enough if you are a freelance medical writer or a small team submitting into a client's system, and your problem is arriving review-ready rather than managing a content lifecycle.

If you already have PromoMats with Claims Management and your content is written in-house against a well-maintained library, you probably do not need us. That is a real answer, and we would rather give it than waste your evaluation cycle.

Plans start at $69/month with self-serve checkout, so testing it on one real piece costs less than a meeting. See how it works.

FAQ

Is PharmaText a Veeva Vault PromoMats alternative? No. PromoMats is a regulated content management system that handles review routing, approvals, versioning, storage and distribution. PharmaText does none of those. It verifies claims against source PDFs at the drafting stage and produces an anchored draft that goes into your system of record.

Does Veeva Vault PromoMats already do claim substantiation? Yes. Veeva's Claims Management module maintains a claims library with linked references, anchors and metadata, and Veeva's Claims Auto Linking reports 80% of claims auto-linked. Veeva has also announced a Claims Agent, available August 2026, for identifying and substantiating claims.

Then why would I use PharmaText too? Mainly when the writer cannot reach the Vault claims library — external agencies and freelancers writing into a client's system — or when the claim is new and not yet in any library, so there is nothing to reuse and the substantiation has to happen against a source PDF directly.

Can PharmaText replace MLR review? No, and nothing should. It makes a submission verifiable rather than reconstructable before it reaches reviewers. The compliance decision stays with the medical, legal and regulatory reviewers. See the MLR review process.

What about Aprimo and Vodori? The same reasoning applies. They are content management and review platforms; PharmaText operates before submission regardless of which system of record you use.

Sources: Veeva product capabilities, metrics and the Claims Agent availability date are taken from Veeva's own public product pages, Veeva Vault PromoMats and Claims Management, accessed August 2026. Figures such as "80% claims auto-linked", "70% claims reuse" and "72% time savings" are Veeva's reported figures, not independently verified. PharmaText is not affiliated with, endorsed by, or a partner of Veeva Systems Inc. Veeva, Vault and PromoMats are trademarks of Veeva Systems Inc.